ABVC BioPharma (ABVC) Stock Chart & Stock Price History → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free ABVC Stock Alerts $1.08 +0.02 (+1.89%) (As of 02:26 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ABVC BioPharma Stock Price Performance5 Day Performance-2.70%1 Month Performance-0.92%3 Month Performance-18.18%6 Month Performance-5.26%Year-To-Date Performance-6.90%1 Year Performance-86.93% Receive ABVC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action ABVC Stock Chart for Monday, May, 13, 2024 ABVC Chart by TradingView ABVC BioPharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$1.10$1.06-3.64%$1.09$1.05206,638 shs$11.19 million05/09/2024$1.11$1.10-0.90%$1.24$1.061.31 million shs$11.62 million05/08/2024$1.06$1.11+4.72%$1.13$1.04553,806 shs$11.72 million05/07/2024$1.08$1.06-1.85%$1.08$1.03259,997 shs$11.19 million05/06/2024$1.08$1.08$1.09$1.03735,481 shs$11.41 million05/03/2024$1.15$1.08-6.09%$1.15$1.07413,386 shs$11.41 million Get the Latest News and Ratings for ABVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$1.13$1.15+1.77%$1.17$1.10308,204 shs$12.14 million05/01/2024$1.25$1.13-9.60%$1.23$1.05980,321 shs$11.93 million04/30/2024$1.40$1.25-10.71%$1.40$1.25752,769 shs$13.20 million04/29/2024$1.42$1.40-1.41%$1.45$1.301.74 million shs$14.78 million04/26/2024$1.59$1.42-10.69%$1.57$1.402.02 million shs$15.00 million04/25/2024$1.48$1.59+7.43%$1.73$1.365.33 million shs$16.79 million04/24/2024$1.35$1.48+9.63%$1.50$1.286.45 million shs$15.63 million04/23/2024$1.04$1.35+29.81%$1.37$1.007.67 million shs$14.26 million04/22/2024$0.99$1.04+5.04%$1.04$0.94307,916 shs$10.98 million04/19/2024$1.05$0.99-5.70%$1.04$0.97167,634 shs$10.46 million04/18/2024$1.02$1.05+2.94%$1.07$0.94459,059 shs$11.09 million04/17/2024$1.12$1.02-8.93%$1.19$1.001.78 million shs$10.77 million04/16/2024$1.09$1.12+2.75%$1.13$1.05109,769 shs$11.83 million04/15/2024$1.09$1.09$1.11$1.05218,100 shs$11.51 million04/12/2024$1.15$1.09-5.22%$1.15$1.08222,465 shs$11.51 million04/11/2024$1.14$1.15+0.88%$1.17$1.10265,141 shs$12.14 million04/10/2024$1.18$1.14-3.39%$1.30$1.063.78 million shs$12.04 million04/09/2024$1.25$1.18-5.60%$1.26$1.17249,003 shs$12.46 million04/08/2024$1.27$1.25-1.57%$1.31$1.25156,549 shs$13.20 million04/05/2024$1.28$1.27-0.78%$1.30$1.2567,591 shs$13.41 million04/04/2024$1.29$1.28-0.78%$1.31$1.25114,803 shs$13.52 million04/03/2024$1.29$1.29$1.30$1.24126,235 shs$13.62 million04/02/2024$1.37$1.29-5.84%$1.35$1.25202,976 shs$13.62 million04/01/2024$1.31$1.37+4.58%$1.41$1.28645,232 shs$14.47 million03/29/2024$1.31$1.31$1.31$1.16678,552 shs$13.83 million03/28/2024$1.20$1.31+9.17%$1.31$1.16670,304 shs$13.83 million03/27/2024$1.28$1.20-6.25%$1.33$1.181.43 million shs$12.67 million03/26/2024$1.05$1.28+21.90%$1.45$1.1527.15 million shs$13.52 million03/25/2024$1.07$1.05-1.87%$1.06$1.03106,302 shs$11.09 million03/22/2024$1.06$1.07+0.94%$1.08$1.0662,105 shs$8.28 million03/21/2024$1.08$1.06-1.85%$1.11$1.0683,561 shs$8.20 million03/20/2024$1.12$1.08-3.57%$1.13$1.06190,875 shs$8.36 million03/19/2024$1.16$1.12-3.45%$1.17$1.10108,502 shs$8.67 million03/18/2024$1.17$1.16-0.85%$1.18$1.1464,098 shs$8.98 millionYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad)While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action03/15/2024$1.20$1.17-2.50%$1.22$1.17127,997 shs$9.06 million03/14/2024$1.23$1.20-2.44%$1.25$1.2064,665 shs$9.29 million03/13/2024$1.26$1.23-2.38%$1.25$1.2176,848 shs$9.52 million03/12/2024$1.22$1.26+3.28%$1.29$1.2159,771 shs$9.76 million03/11/2024$1.25$1.22-2.40%$1.26$1.2271,572 shs$9.44 million03/08/2024$1.25$1.25$1.29$1.2455,751 shs$9.68 million03/07/2024$1.24$1.25+0.81%$1.26$1.2139,513 shs$9.60 million03/06/2024$1.21$1.24+2.48%$1.25$1.2085,387 shs$9.60 million03/05/2024$1.24$1.21-2.42%$1.25$1.2059,411 shs$9.37 million03/04/2024$1.18$1.24+5.08%$1.27$1.19148,854 shs$9.60 million03/01/2024$1.21$1.18-2.48%$1.22$1.15135,775 shs$9.13 million02/29/2024$1.22$1.21-0.41%$1.23$1.1893,283 shs$9.37 million02/28/2024$1.23$1.22-1.22%$1.24$1.2193,737 shs$9.40 million02/27/2024$1.24$1.23-0.81%$1.25$1.2259,773 shs$9.53 million02/26/2024$1.20$1.24+3.33%$1.25$1.1880,883 shs$9.60 million02/23/2024$1.21$1.20-0.83%$1.21$1.1678,389 shs$9.29 million02/22/2024$1.19$1.21+1.68%$1.27$1.1746,426 shs$9.37 million02/21/2024$1.20$1.19-0.83%$1.21$1.15142,041 shs$9.21 million02/20/2024$1.27$1.20-5.51%$1.28$1.19167,158 shs$9.29 million02/19/2024$1.27$1.27$1.29$1.25176,900 shs$9.83 million02/16/2024$1.28$1.27-0.78%$1.29$1.25176,180 shs$9.83 million02/15/2024$1.26$1.28+1.59%$1.32$1.24291,801 shs$9.91 million02/14/2024$1.32$1.26-4.55%$1.33$1.26168,846 shs$9.75 million02/13/2024$1.34$1.32-1.49%$1.34$1.3075,782 shs$10.22 million02/12/2024$1.32$1.34+1.52%$1.35$1.26463,445 shs$10.38 million Related Companies: AgeX Therapeutics Stock Chart MIRA Pharmaceuticals Stock Chart Monopar Therapeutics Stock Chart Elevai Labs Stock Chart Moleculin Biotech Stock Chart NanoViricides Stock Chart RedHill Biopharma Stock Chart Akari Therapeutics Stock Chart Galera Therapeutics Stock Chart Purple Biotech Stock Chart Receive ABVC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABVC) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDoes this make you sick?Allegiance GoldBill Clinton Backing Biden Replacement???The Freeport SocietyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.